Acino: Acino completes acquisition of M8 Pharmaceuticals significantly expanding presence and capabilities in Latin America

Acino today announced that it has completed the acquisition of M8 Pharmaceuticals (M8), a fast-growing specialty biopharmaceutical company, headquartered in Mexico City and focused on licensing, marketing, and distributing innovative and established medicines in Mexico and Brazil.